Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ryoko Omori‐Shimada"'
Autor:
Takuya Izumiyama, Yu Mori, Itsuki Oizumi, Soshi Hamada, Hiroaki Kurishima, Hitoshi Terui, Ryoko Omori-Shimada, Kenshi Yamasaki, Eiji Itoi
Publikováno v:
Journal of Orthopaedic Surgery, Vol 29 (2021)
Objectives: The patient of severe psoriatic arthritis (PsA) is mainly treated with oral methotrexate, ciclosporin, and anti-tumor necrosis factor-alpha inhibitors (TNFi). Recently, anti-interleukin-17A inhibitors (IL-17Ai) have been used in the treat
Externí odkaz:
https://doaj.org/article/65b75ce44eef42119609e35cf50c9061
Autor:
Moyuka Wada‐Irimada, Haruka Yamamoto, Hitoshi Terui, Ryoko Omori‐Shimada, Emi Yamazaki, Katsuko Kikuchi, Setsuya Aiba, Kenshi Yamasaki
Publikováno v:
The Journal of dermatologyREFERENCES. 49(5)
Rosacea is a chronic inflammatory skin disease with facial redness and acne-like papules and pustules. The characteristics and background of rosacea patients in Japan have not been well documented. In this study, we retrospectively collected the medi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee8395ba29cc0348a6842ff1463a5c2a
https://pubmed.ncbi.nlm.nih.gov/35174900
https://pubmed.ncbi.nlm.nih.gov/35174900
Autor:
Yu Mori, Takuya Izumiyama, Itsuki Oizumi, Hitoshi Terui, Soshi Hamada, Kenshi Yamasaki, Hiroaki Kurishima, Eiji Itoi, Ryoko Omori-Shimada
Publikováno v:
Journal of Orthopaedic Surgery, Vol 29 (2021)
Objectives: The patient of severe psoriatic arthritis (PsA) is mainly treated with oral methotrexate, ciclosporin, and anti-tumor necrosis factor-alpha inhibitors (TNFi). Recently, anti-interleukin-17A inhibitors (IL-17Ai) have been used in the treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4902d2b9c93de204ce2fc395dd81f3d
https://pubmed.ncbi.nlm.nih.gov/33938296
https://pubmed.ncbi.nlm.nih.gov/33938296